phthivazide has been researched along with isoniazid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Boufadi, MY; Dufrasne, F; Furtmüller, PG; Gelbcke, M; Meyer, F; Nève, J; Obinger, C; Soubhye, J; Van Antwerpen, P; Zouaoui Boudjeltia, K | 1 |
Franzblau, SG; Hu, X; Liu, Z; Lu, X; Wan, B; Wang, R; You, Q; Zhang, T | 1 |
Farias, AB; Henriques, RR; Junior, MAAL; Nogueira, TLDC; Quimas, JVF; Romeiro, NC; Santos, DC; Silva, LLD; Souza, ALF | 1 |
3 other study(ies) available for phthivazide and isoniazid
Article | Year |
---|---|
From Dynamic Combinatorial Chemistry to
Topics: | 2017 |
Benzylsulfanyl benzo-heterocycle amides and hydrazones as new agents against drug-susceptible and resistant
Topics: | 2017 |
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Biphenyl Compounds; Chelating Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophorus; Humans; Hydrazones; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Peroxidase; Picrates; Structure-Activity Relationship | 2020 |